Jing Wang

Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus

K. Reddy, E. Gane, D. Brainard, 2015, Hepatology.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

T. Berg, T. Asselah, A. Mangia, 2015, The New England journal of medicine.

Ledipasvir/Sofosbuvir-Based Treatment of Patients with Chronic Genotype-1 HCV Infection and Cirrhosis: Results from Two Phase II Studies

H. Dvory‐Sobol, D. Brainard, J. McHutchison, 2016, Antiviral therapy.

Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus

K. Reddy, E. Gane, D. Brainard, 2015, Hepatology.